May, 2013 | The Wall Street Analyzer

Latest News

[ June 10, 2021 ] Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US News Feed
[ June 9, 2021 ] GOLDEN INDEPENDENCE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING News Feed
[ June 4, 2021 ] Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules News Feed
[ June 4, 2021 ] City View Green Holdings Inc. and Budd Hutt Inc. Open Second Retail Cannabis Store in Grande Cache, Alberta News Feed
[ June 3, 2021 ] Golden Independence Announces Private Placement Financing News Feed
[ May 26, 2021 ] Citius Pharmaceuticals Selected to Receive Best Poster Award at the International Society for Cell and Gene Therapy 2021 Annual Meeting News Feed
[ May 19, 2021 ] Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia News Feed

Potash Ridge CEO Mr. Guy Bentinck Presenting at 2013 Potash and Sylvite Conference

May 31, 2013 The Wall Street Analyzer Comments Off

June 3rd in China […]

Support.com (NASDAQ: SPRT) CEO: Josh Pickus

May 29, 2013 The Wall Street Analyzer Comments Off

Interview with Josh Pickus, CEO […]

Professional Diversity Network (NASDAQ:IPDN) CEO Interview

May 29, 2013 The Wall Street Analyzer Comments Off

Interview with James Kirsch, CEO and Rudy Martinez Executive VP […]

CytoSorbents Featured in MedCity News

May 29, 2013 The Wall Street Analyzer Comments Off

CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to treat life-threatening illnesses in the intensive care unit, was recently featured in the article “Blood Purification Device for ICU Patients Seeks to […]